The OLS has just launched the Biomanufacturing Fund (BMF) to support life science companies investing in manufacturing projects in the UK. The BMF will provide up to £38 million in capital grants to incentivise investment in the manufacture of vaccines and biotherapeutics, to improve the UK’s health resilience for future pandemics.
The BMF follows on from the £60m Life Sciences Innovative Manufacturing Fund (LSIMF) and will be using the same process as LSIMF for delivering the grants.
There are two upcoming opportunities to apply, with monthly deadlines of 30th June and 31st July. If you think you could benefit from this fund please contact the BMF team at bmf@officeforlifesciences.gov.uk You can find out more details about the fund at this webpage
Read our other news
CHESTER’S first large-scale build-to-rent scheme will see a 176-apartment development just minutes from Chester train station.
A concrete wall to provide radiological shielding at a Cheshire business has been given permission by council planners.
Royal Mail has introduced fully electric vans at its Ellesmere Port Delivery Office as part of a national rollout, cutting emissions and supporting jobs in the area.